Analysis of another 333 cases of COVID-19 inpatients treated between 2020-2022, with increasing doses of colchicine, showed a clear trend of a reduction in mortality between 2- and 7-fold is submitted for publication.
← all excerpts
High Doses of Colchicine Act As "Silver Bullets" Against Severe COVID-19.
1
—
—